share_log

景峰医药(000069.SZ):公司股票可能被实施退市风险警示

Jingfeng Pharmaceutical (000069.SZ): The company's stock may be subject to a delisting risk warning

Zhitong Finance ·  Mar 29 09:03

Jingfeng Pharmaceutical (000069.SZ) issued an announcement. According to preliminary estimates by the company's finance department, the company expects 2023...

Zhitong Finance App News, Jingfeng Pharmaceutical (000069.SZ) issued an announcement. According to preliminary estimates by the company's finance department, the company's net assets are expected to be negative at the end of 2023. If the company's net assets at the end of the 2023 audited period are negative, according to the relevant provisions of the “Shenzhen Stock Exchange Stock Listing Rules”, the company's stock transactions will be subject to a delisting risk warning after disclosing the 2023 annual report.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment